logo
Hot dog production ramps up ahead of Memorial Day weekend, summer season

Hot dog production ramps up ahead of Memorial Day weekend, summer season

Yahoo23-05-2025

Memorial Day weekend is what kicks off the start of a busy time of the year for one local company best known for its hot dogs.
Representatives from Smith's Provisions said they got off to a bit of a late start this year due to producing hams for Easter, but they've ramped up hot dog production ever since.
Presque Isle beaches set to open for season Memorial Day Weekend
Five weeks ago, they started building up a massive inventory of hot dogs for people to enjoy on holiday weekends and throughout the summer.
'Obviously, Memorial Day is about those who have served and sacrificed, and at Smith's here, we just hope as part of that celebration, when you're celebrating those people, you choose to serve Smith's to your family and friends at that time,' said Ray Kallner, vice president of sales, marketing and business administration for Smith's. 'Right now, the stores are jam-packed with product, so you shouldn't have trouble finding us.'
Kallner said they produce anywhere from 20 to 25 million hot dogs in a year, and about 60%-70% are sold between now and the end of July
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Nika Pharmaceuticals, Inc. to Present at the Life Sciences Virtual Investor Forum June 11th-12th
Nika Pharmaceuticals, Inc. to Present at the Life Sciences Virtual Investor Forum June 11th-12th

Yahoo

timean hour ago

  • Yahoo

Nika Pharmaceuticals, Inc. to Present at the Life Sciences Virtual Investor Forum June 11th-12th

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at HENDERSON, Nev., June 10, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB:NIKA), based in Colorado, focused on cures for life-threatening diseases, today announced that Dimitar Savov, CEO, will present live at the Life Sciences Virtual Investor Frum hosted by on June 11th, 2025 DATE: June 11th TIME: 1:00 PM ETLINK: REGISTER HEREAvailable for 1x1 meetings: June 12th-17th between 09:00am ET and 11:30am ET This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at Recent Company Highlights On May 19, 2025, NIKA published a market analysis for the countries of Ukraine, Syria, Jordan, Iraq, UAE, where NIKA has exclusive distribution agreements and has estimated a total of around €656 million in potential revenue. NIKA's partner company, Nika Europe, has made the second $195,554 payment for the vial production line and is currently finalizing the details of the clean rooms design in order to start construction. The production facility is expected to be completed in H2, 2025. On April 11, 2025, Nika Pharmaceuticals, Inc. published a report on the therapeutic effect and potential economic impact of ITV-1, which can be found here. On July 11, 2024 Nika Pharmaceuticals, Inc. signed an exclusive distribution agreement for the Republic of Nigeria. Under the terms, NIKA will receive €1,980 per each set of ITV-1 with two sets necessary for each treatment, which could result in €7.9 billion revenue. About Nika Pharmaceuticals, Inc. Nika Pharmaceuticals, Inc. (NIKA) is a pharmaceutical company, specializing in the treatment of HIV/AIDS, Hepatitis B and C, Rheumatoid Arthritis, Cancer, Diabetes, and all diseases, for which strengthened cell immunity is of vital importance. NIKA's intellectual property includes six drugs in injection form – two of which have successfully undergone clinical trials with good treatment results – four drugs in tablet form, and eleven dietary supplements. NIKA's goal is to not only achieve corporate profits, but to provide better and easier access to life-saving medicinal drugs and useful dietary supplements. Find more on Forward-looking Statement: This press release contains forward-looking statements. Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are 'forward- looking statements.' These forward-looking statements generally are identified by the words 'believes,' 'expects,' 'anticipates,'' estimates,' 'intends,' 'strategy,' 'plan,' 'may,' 'will,' 'would,' 'will be,' 'will continue,' 'will likely result,' and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. About Virtual Investor Conferences®Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors. CONTACTS:Nika Pharmaceuticals, Clifford P. RedekopTitle Corporate SecretaryPhone (702) 326-3615 Email cliffredekop@ Virtual Investor Conferences John M. ViglottiSVP Corporate Services, Investor AccessOTC Markets Group (212) 220-2221johnv@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Guided Therapeutics Receives $700,000 Purchase Order and Initial Payment from New Chinese Distributor
Guided Therapeutics Receives $700,000 Purchase Order and Initial Payment from New Chinese Distributor

Business Wire

timean hour ago

  • Business Wire

Guided Therapeutics Receives $700,000 Purchase Order and Initial Payment from New Chinese Distributor

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a purchase order and first payment from Hangzhou Dongye Medical Technology Company Ltd (HDMT) for 35 LuViva systems. HDMT will order directly from Guided Therapeutics and the devices will be assembled and tested by Guided Therapeutics' Chinese partner, Shandong Yaohua Medical Instrument Corporation (SMI). HDMT is in Hangzhou City, Zhejiang Province, where it is the exclusive gynecology products provider for 42 hospitals that perform approximately two million cervical cancer screenings annually. Said Yang Dongye, CEO of HDMT: 'We are extremely impressed with the performance of LuViva and our goal is to eventually replace the current screening tests with LuViva.' The purchase order for $700,000 is to supply HDMT with 35 systems over the next eight months starting in July of this year. 'We are extremely pleased to be working with HDMT to bring LuViva to Zhejiang Province and anticipate making initial shipments next month,' added Mark Faupel, Guided Therapeutics' CEO. 'Working directly with an exclusive provider of gynecology products that can potentially conduct two million LuViva tests each year is a major advance for GTI.' About Guided Therapeutics Guided Therapeutics, Inc. (OTCQB: GTHP) is the maker of a rapid and painless testing platform based on its patented biophotonic technology that utilizes light for the early detection of disease at the cellular level. The Company's first product is the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial with women at risk for cervical disease, the technology was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. For more information, visit: The Guided Therapeutics LuViva ® Advanced Cervical Scan is an investigational device and is limited by federal law to investigational use in the U.S. LuViva, the wave logo and "Early detection, better outcomes" are registered trademarks owned by Guided Therapeutics, Inc. Forward-Looking Statements Disclaimer: A number of the matters and subject areas discussed in this news release that are not historical or current facts deal with potential future circumstances and developments. The discussion of such matters and subject areas is qualified by the inherent risks and uncertainties surrounding future expectations generally and also may materially differ from Guided Therapeutics' actual future experience involving any of or more of such matters and subject areas. Such risks and uncertainties include those related to the early stage of commercialization of products, the uncertainty of market acceptance of products, the uncertainty of development or effectiveness of distribution channels, the intense competition in the medical device industry, the sufficiency of capital raised in prior financings and the ability to realize their expected benefits, the uncertainty of future capital to develop products or continue as a going concern, the uncertainty of regulatory approval of products, and the dependence on licensed intellectual property, as well as those that are more fully described from time to time under the heading 'Risk Factors' in Guided Therapeutics' reports filed with the SEC, including Guided Therapeutics' Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and subsequent filings.

Market 32 and Price Chopper Partner with Konekt.io to Launch Seasonal Campaign to Drive Loyalty and Digital Engagement
Market 32 and Price Chopper Partner with Konekt.io to Launch Seasonal Campaign to Drive Loyalty and Digital Engagement

Business Wire

timean hour ago

  • Business Wire

Market 32 and Price Chopper Partner with Konekt.io to Launch Seasonal Campaign to Drive Loyalty and Digital Engagement

SCHENECTADY, N.Y.--(BUSINESS WIRE)-- Market 32 and Price Chopper, a division of Northeast Grocery, Inc. (NGI), is running an omnichannel summer promotion to be the destination for your summer grocery and entertaining needs called Summer Shines Here. Featured elements run from Memorial Day to Labor Day and are designed to drive customer loyalty, boost sales and deepen digital engagement. The overarching campaign will include specials on season-appropriate grocery items, recipes for summertime meals, sweepstakes for the summer, and broad-based digital support across owned and paid media. 'We're thrilled to partner with Market 32 and Price Chopper on the launch of their new gamified bonus points feature alongside the Summer Doubler,' said Ashmit Bhattacharya, CEO of A key pillar of the campaign is the Summer Doubler, which gives AdvantEdge Rewards members the opportunity to earn double points on all qualifying purchases throughout the summer. To further boost engagement, the Summer Doubler introduces a gamified bonus points experience where members can spin a digital carnival-style wheel twice over the summer—once at the campaign's launch and again during a mid-summer pulse moment—to win 100 to 500 bonus points. These components, developed with a retail tech company providing payments, loyalty and prepaid services to retailers around the world, will maximize shopper digital engagement and drive in-store sales. 'We've seen consistent sales increases from points multiplier promotions through the AdvantEdge Rewards program during the past few years. This year, we are elevating the concept by weaving in gamification to drive engagement,' said Blaine Bringhurst, president of Market 32 and Price Chopper. 'We're excited to add this new twist to one of our flagship marketing promotions. It's a great example of how we use our deep understanding of consumer preferences and behavior to create meaningful value, aligned with how our customers shop and want to engage with our brand,' added Sam Trimboli, director of shopper experience and research for Market 32 and Price Chopper. Digital engagement is an important aspect of Market 32 and Price Chopper's AdvantEdge Rewards program. In addition to earning points for grocery spending and redeeming points for food and fuel rewards, Market 32 and Price Chopper offer its members additional ways to earn and redeem points on their site and app. 'Like many retailers, we see that our most engaged digital customers are also our highest spenders. We're committed to continually enhancing the value we deliver to them through our AdvantEdge Rewards program,' added Bringhurst. The online AdvantEdge Rewards experience and the Summer Doubler are supported by 'We're thrilled to partner with Market 32 and Price Chopper on the launch of their new gamified bonus points feature alongside the Summer Doubler. Together, these elements deliver fresh ways to create value and deepen engagement with AdvantEdge Rewards members,' said Ashmit Bhattacharya, CEO of To start earning enhanced rewards, shoppers can join the AdvantEdge Rewards program for free by signing up for an AdvantEdge Card and activating the Summer Doubler via the Market 32 and Price Chopper app or website starting May 25, 2025. About Northeast Grocery, Inc. Headquartered in Schenectady, NY, Northeast Grocery, Inc. (NGI) is the parent company of Market 32, Price Chopper, and Tops Friendly Markets, which collectively operate nearly 300 supermarkets across New York, Massachusetts, Vermont, Connecticut, Pennsylvania, and New Hampshire and employ more than 30,000 teammates/associates. NGI is No. 46 on The PG 100, Progressive Grocer's 2025 list of the top food and consumables retailers in North America. With more than 150 years of industry leadership combined, Market 32, Price Chopper, and Tops share longstanding traditions of innovative food merchandising and exceptional customer service and are driven to provide sustainably sourced, high-quality products to nourish the communities in which they operate while reducing environmental waste and energy consumption. For additional information, please visit and About — Embedded Finance and Loyalty, Built for Retail Based in New York, operates in 15 countries across three continents, with a presence in over 150,000 stores and more than $3 billion in annual digital payment volume. For over a dozen years, has partnered with the world's largest retailers, delivering innovative solutions in payments, loyalty and prepaid. For additional information, please visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store